IOPAMIRO

This brand name is authorized in Estonia, Spain, Hong Kong, Croatia, Lithuania, Romania, Singapore, Turkey

Active ingredients

The drug IOPAMIRO contains one active pharmaceutical ingredient (API):

1 Iopamidol UNII 9679TC07X4 - IODINE

Iopamidol is contrast medium belonging to the new generation of non-ionic compound whose solubility is due to the presence of hydrophilic substitutes in the molecule. This results in a solution of low osmollity when compared with ionic media. Read about Iopamidol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V08AB04	Iopamidol	V Various → V08 Contrast media → V08A X-ray contrast media, iodinated → V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media
Discover more medicines within V08AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1121342, 1121353, 1121364, 1121375, 1121397, 1121409, 1121410, 1121421, 1130757, 1526138, 1526149
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 57272, 57273
Country: HK	Department of Health Drug Office	Identifier(s): 23812, 23813
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-140733276, HR-H-213064000
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1011305, 1011306, 1011307, 1011308, 1011309, 1011310, 1011311, 1011312, 1090209, 1090210
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W03756002, W03756003, W03756004, W03757003, W03757004, W03757005, W03757006
Country: SG	Health Sciences Authority	Identifier(s): 05906P, 05907P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699564772212, 8699564772229, 8699564772236, 8699564772250, 8699564772311, 8699564772328, 8699564772335, 8699564772359